Gameto, an Austin, TX-based clinical-stage biotechnology company developing stem cell-derived therapies for reproductive health, raised $44M in Series C funding

Want to help push aging biology research forward? 🚀 You can make an impact today: 📝 Speak up — Contact your local representatives and state senators. Email us at info@a4li.org for tips on what to say. 💬 Share your story — Tell us why this research matters to you:

The time is now for thoughtful longevity policy. Please read this op-ed: @theA4LI

Super excited about @foresightinst and their new Bio & Nano Grants -- fast turnaround of small grants to help frontier longevity biotechnology or molecular nanotechnology ideas and projects get off the ground. If that’s you, I encourage you to apply here:

Over-exercising induces irreversible liver fibrosis (who knew?) by inducing the secretion of damaging vesicles from muscles called “lactate bodies” @Cell_Metabolism

Congrats to the Gameto team on FDA clearance for the Phase 3 trial of a technology that makes IVF easier on women!

(1/) I am thrilled to announce that @GametoGen has received FDA clearance to launch our Phase 3 clinical trial for Fertilo - the first iPSC-based therapy to enter this stage since Shinya Yamanaka’s Nobel Prize-winning discovery of iPSCs.

I’d like to introduce you to Death Clock—an AI-powered longevity app that I’ve been advising for the last 6 months. Health apps are notoriously difficult to grow: they are single-player utilities that resonate most with older audiences. However, I worked with the founder

🌟 Exciting News for the Future of Health and Longevity! 🌟 We’re thrilled to officially announce the launch of LongeviPAC — the first political action committee dedicated to advancing pro-longevity policies in the United States! 🚀 🔗 https://t.co/FgZQH7fxD6 🧵1/8

In March 2024, we hosted our inaugural D.C. Fly-In, bringing together industry leaders, academics, investors, and policymakers. Despite the challenges of navigating a potential government shutdown, we successfully showcased the importance of representing the longevity science

Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body -

The success of AI applied to drug discovery is being decided by a number of clinical trials. So far, the results are lackluster. Why? For AI to have a transformational effect in drug discovery, training data must come from living mammals. (🧵1/9)

https://t.co/rM1m2vtaTV

FDA approves new blood test to screen for colon cancer https://t.co/iD1qitOuC8 via @nbcnews

Shouldn’t aging be part of drug discovery for diseases of aging? https://t.co/fvnzoiahrJ Gordian exists to move therapeutic testing from plastic wells and young mice into a living environment with all the complexity present in patients with age-related disease. We’re now

Join us for The Alliance for Longevity Initiatives (A4LI)'s inaugural D.C. Fly-In event on March 20-21, 2024! This groundbreaking gathering will unite leading scientists and policymakers committed to advancing legislative and policy initiatives that promote healthy human

The Alliance for Longevity Initiatives (A4LI) is thrilled to announce the newest addition to our team, Brenda Eap, PhD, who joins us as our Vice President of Operations and Partnerships. Brenda brings with her a wealth of expertise and dedication to our mission of advancing

The Advanced Research Projects Agency for Health (ARPA-H) has announced that they will be providing $37 million in project funding to The Thymus Rejuvenation project. Making it the first industry project to receive support through the ARPA-H Open BAA. The project, led by

Congrats to @GametoGen & @DinaRadenkovic for developing a safer, shorter, and more accessible IVF and egg-freezing experience for women.

Congratulations, Aydin! Another awesome accolade.